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The benefit of exercise training in congestive heart failure
(CHF) has become widely appreciated over the past 20 years.
It is now clear that exercise exerts a number of beneficial
effects in CHF, including an improvement of skeletal muscle
perfusion, and metabolism, breathing efficiency, and neuro-
humoral activation [1]. More recent evidence indicates that
exercise training in patients with CHF also improves cardiac
function [2], which is in agreement with observations in
animal models of CHF and appears mediated by exercise-
induced amelioration of CHF-associated interstitial fibrosis
and cardiomyocyte dysfunction and apoptosis [3]. These ben-
eficial effects of exercise are the consequence of the activation
of different molecular signalling pathways that drive the tran-
scriptional control of cardiac remodelling in exercise training
versus CHF [1, 3, 4].
In this issue of the Netherlands Heart Journal the Dutch
Royal Society for Physiotherapy (KNGF) presents practical
guidelines for exercise-based cardiac rehabilitation of patients
with CHF [5]. Interestingly, the number of national guidelines
in clinical cardiology in most European countries is currently
declining, which is due to a number of reasons. First, scientific
collaboration among national cardiology societies in Europe
has become very close within the European Society of Cardi-
ology (ESC) and even large countries such as Germany now
no longer produce national guidelines, e.g. for myocardial
revascularisation, but issue a German translation of the ESC
pocket guideline accompanied by a ‘commentary’ that puts
ESC recommendations into a national perspective. Second,
the scientific standards to produce guidelines have been con-
tinually raised over the last two decades: To assess the evi-
dence base a large and continually increasing number of
published studies need to be assessed for quality in order to
be included in meta-analyses. This process can only be ac-
complished with professional bibliographic and statistical
help and requires significant resources. So why did the Dutch
Royal Society for Physiotherapy engage in the painstaking
task of producing national guidelines for exercise-based car-
diac rehabilitation (CR) of patients with chronic CHF? In
contrast to most areas of acute care, the financing, infrastruc-
ture, and medical quality of the CR program differ significant-
ly between European countries. It may therefore make sense
to develop a practical guideline particularly targeted to the
clinical situation in the Netherlands. Additionally, the Dutch
Royal Society for Physiotherapy represents physiotherapists
rather than clinical cardiologists and therefore takes a different
perspective of allied health personnel on how to implement
the treatment strategies that cardiologists or rehabilitation
physicians may have recommended. Consequently, it is much
more detailed than usual cardiology guidelines in the practical
aspects of patient functional assessment, patient education and
empowerment, and the actual training program [5, 6].
The key messages of these guidelines are: (i) Aerobic
endurance training at 50–80 % of VO2 peak remains the
training intervention of choice for most CHF patients, espe-
cially those in advanced stages of functional impairment.
High-intensity interval training (HIT) can be recommended
in relatively low-risk CHF patients to achieve higher training
effectiveness. (ii) Objective assessment of maximal functional
capacity by cardiopulmonary exercise testing is a precondition
for optimal individual determination of recommended training
intensities. (iii) Useful optional components of the training
programme may comprise inspiratory muscle training,
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strength training, and relaxation therapy. Patient assessment
can help to identify patients who benefit from these program
components (i.e. Pimax < 70 % predicted, significant muscle
wasting, high anxiety levels). (iv) Exercise training is only
effective as long as it is maintained. Therefore, continuation of
regular physical activity and training after the cardiac rehabil-
itation phase needs to be encouraged and - if possible -
monitored.
However, because this is a guideline for physiotherapists it
does not address several important issues, which are relevant
for the general clinical cardiologist, including: (i) How can we
identify CHF patients who may particularly benefit from
training therapy? (ii) How to assess the patient’s individual
risk before the initiation of training therapy? (iii) What are the
inclusion and exclusion criteria for training interventions in
CHF? (iv) What invasive/non-invasive diagnostic testing
should be performed prior to transferral for training therapy?
For all these questions, physicians should consult the position
paper from the European Association of Cardiovascular Pre-
vention and Rehabilitation [7]. In the setting of chronic CHF,
peak exercise capacity should be determined by maximal
symptom-limited cardiopulmonary exercise testing with small
5 to 10 W/min increments. In known ischaemic heart disease
exercise-induced myocardial ischaemia should be determined
and exercise levels should be below the ischaemic threshold.
If cardiopulmonary exercise-testing equipment is not avail-
able, submaximal tests, such as the 6-min walk test, should be
considered [8]. A baseline echocardiogram is recommended
to assess left ventricular systolic function, and to exclude
potentially correctable conditions such as high-grade mitral
regurgitation prior to the initiation of training therapy.
Notwithstanding the medical conditions required to qualify
for training therapy, it is essential for physicians not to with-
hold the benefits of rehabilitation from their patients. Thus,
current referral rates for cardiac rehabilitation range between
12 % in US Medicare patients and 70 % in middle European
countries with well-developed rehabilitation systems [9, 10].
In large reviews on referral strategies and enrolment rates in
cardiac rehabilitation, automatic referral orders and liaison
methods have been identified as the most useful strategies to
improve referral rates [11]. In the end, however, it comes
down to the patient’s and the physician’s conviction that
cardiac rehabilitation is needed to achieve optimal clinical
outcome [12]. Hence, it is up to us to educate all patients with
CHF that there is a clear dose–response relation between
training intensity (as measured by MET-hours per week) and
outcome improvement indicating significant reductions in
adjusted hazard ratios for all cause/cardiac mortality or all-
cause/cardiac hospitalisation between 3 and 7 MET-hours per
week [13].
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